Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others (Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020


#144864

85pages

Transparency Market Research

$ 5795

In Stock

Cervical cancer is a medical condition in which cells present in the lining of the cervix - gradually develop into pre-cancerous mass of cells that ultimately turn into cancerous tumors. Two major types of cervical cancers that are typically screened and diagnosed in women include adenocarcinoma and squamous cell carcinoma. At the same time, it has been observed that approximately 90% cases of cervical cancers are squamous cell carcinoma. Virtually, almost all the cases of cervical cancer cases are due to specific types of human papillomavirus and there are more than 100 different types of HPV virus present, of which nearly 40 are sexually transmitted. Among these, about 15 different types HPV viruses are considered as high-risk type or cancer causing. Today, cervical cancer is recognized to be one of the most common types of cancers affecting U.S. women and ranks 14th in frequency. Worldwide, cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 300,000 deaths annually.

 

This research report provides a detailed analysis of the global cervical cancer diagnostic tests market and helps in understanding the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. The executive summary provides detailed insights about the report and the market in general. It also contains a market snapshot, which provides a glimpse into the present scenario of the global cervical cancer diagnostic tests market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global cervical cancer diagnostic tests market. 

 

The global cervical cancer diagnostic tests market is segmented based on types of tests performed for the diagnosis of cancer patients. Based on the test types, the market is segmented into Pap smear tests, HPV testing, colposcopy, endocervical curettage procedure and others, which comprise cone biopsy and Loop Electrosurgical Excision Procedure (LEEP). Market size estimates and forecasts for the period 2012 to 2020 have been provided for each of the segments mentioned above in terms of USD million, considering 2013 as the base year for calculating market forecast and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period 2014 to 2020 has also been provided along with market size estimations.

 

Geographically, the global cervical cancer diagnostic tests market has been segmented into four major regional markets: North America, Europe, Asia Pacific and Rest of World (RoW). The market size estimations and forecasts for the period 2012 to 2020 have been provided for each of these regions at a segment level, in terms of USD million along with the CAGR for the forecast period 2014 to 2020. This study further offers market recommendations for the global cervical cancer diagnostic tests market. These include factors that may play a critical role in enhancing or boosting the market in the near future, as well as steps that need to be considered to ensure success for manufacturers. 

 

The report concludes with the company profiles section and includes key information about the major players who are actively participating in this market. The company profiles included in the report are framed in terms of company overview, financial overview, business strategies, recent developments and product portfolio. Key players profiled in this report include Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., OncoHealth Corp.,

Table of Contents

 

Chapter 1 Introduction

1.1 Report Description

1.2 Research Methodology

1.3 Market Segmentation

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Cervical Cancer Diagnostic Tests Market

2.2 Global Cervical Cancer Diagnostic Tests Market, by Type of Tests, 2013 (USD Million)

2.3 Comparative Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography, 2013 & 2020 (Value %)

 

Chapter 3 Market Overview

3.1 Introduction

3.2 Market Dynamics

3.2.1 Market Drivers

3.2.1.1 Rising prevalence rate of cervical cancer expected to boost market growth

3.2.1.2 High incidence rate of HPV infections likely to drive the growth of the market

3.2.1.3 Increasing cervical cancer screening awareness programs assisting in accelerating market growth

3.2.1.4 Breakthrough products and technologies likely to fuel the growth of the market

3.2.2 Market Restraints

3.2.2.1 Lack of appropriate primary healthcare infrastructure to impede the growth of the market

3.2.2.2 Low awareness hinders the growth of the market

3.2.3 Market Opportunities

3.2.3.1 Strengthening distribution network in emerging markets

3.3 Porter’s Five Forces Analysis

3.3.1 Bargaining Power of Suppliers

3.3.2 Bargaining Power of Buyers

3.3.3 Threat of New Entrants

3.3.4 Threat of Substitutes

3.3.5 Competitive Rivalry

3.4 Market Attractiveness Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography

3.5 Heat Map Analysis for Cervical Cancer Diagnostic Tests Market, by Key Market Players

 

Chapter 4 Global Cervical Cancer Diagnostic Tests Market, by Type of Test

4.1 Introduction

4.1.1 Global Cervical Cancer Diagnostic Tests Market Revenue, by Type of Tests, 2012 – 2020 (USD Million)

4.2 Pap Smear Tests

4.2.1 Global Pap Smear Tests Market Revenue, 2012 – 2020 (USD Million)

4.3 Colposcopy

4.3.1 Global Colposcopy Market Revenue, 2012 – 2020 (USD Million)

4.4 HPV Testing

4.4.1 Global HPV Testing Market Revenue, 2012 – 2020 (USD Million)

4.5 Endocervical Curettage (ECC)

4.5.1 Global Endocervical Curettage (ECC) Market Revenue, 2012 – 2020 (USD Million)

4.6 Others [Cone biopsy and Loop Electrosurgical Excision Procedure (LEEP)]

4.6.1 Global Other Cervical Cancer Diagnostic Tests Market Revenue, 2012 – 2020 (USD Million)

 

Chapter 5 Global Cervical Cancer Diagnostics Tests Market, by Geography

5.1 Overview

5.1.1 Global Cervical Cancer Diagnostic Tests Market Revenue, by Geography, 2012-2020 (USD Million)

5.2 North America

5.2.1 North America Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

5.3 Europe

5.3.1 Europe Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

5.4 Asia Pacific

5.4.1 Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

5.5 Rest of the World (RoW)

5.5.1 RoW Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

 

Chapter 6 Recommendations

6.1 Success Strategies (Key Focus Areas)

6.1.1 Gain Accreditation to Ensure Qualification to Participate in National Screening Programs across the Regions

6.1.2 Target Emerging Markets of Asia Pacific and RoW

6.1.3 Intensify Promotion and Training Programs for Healthcare Professionals

6.1.4 Emphasis on Research and Development to come up with Innovative Solutions

 

Chapter 7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Company Overview

7.1.2 Financial Overview

7.1.3 Product Portfolio

7.1.4 Business Strategies

7.1.5 Recent Developments

7.2 Becton, Dickinson and Company

7.2.1 Company Overview

7.2.2 Financial Overview

7.2.3 Product Portfolio

7.2.4 Business Strategies

7.2.5 Recent Developments

7.3 Hologic, Inc.

7.3.1 Company Overview

7.3.2 Financial Overview

7.3.3 Product Portfolio

7.3.4 Business Strategies

7.3.5 Recent Developments

7.4 F. Hoffmann-La Roche Ltd.

7.4.1 Company Overview

7.4.2 Financial Overview

7.4.3 Product Portfolio

7.4.4 Business Strategies

7.4.5 Recent Developments

7.5 Quest Diagnostics, Inc.

7.5.1 Company Overview

7.5.2 Financial Overview

7.5.3 Product Portfolio

7.5.4 Business Strategies

7.5.5 Recent Developments

7.6 QIAGEN N.V.

7.6.1 Company Overview

7.6.2 Financial Overview

7.6.3 Product Portfolio

7.6.4 Business Strategies

7.6.5 Recent Developments

7.7 Femasys, Inc.

7.7.1 Company Overview

7.7.2 Financial Overview

7.7.3 Product Portfolio

7.7.4 Business Strategies

7.7.5 Recent Developments

7.8 Zilico Ltd.

7.8.1 Company Overview

7.8.2 Financial Overview

7.8.3 Product Portfolio

7.8.4 Business Strategies

7.8.5 Recent Developments

7.9 Guided Therapeutics, Inc.

7.9.1 Company Overview

7.9.2 Financial Overview

7.9.3 Product Portfolio

7.9.4 Business Strategies

7.9.5 Recent Developments

7.10 OncoHealth Corp.

7.10.1 Company Overview

7.10.2 Financial Overview

7.10.3 Product Portfolio

7.10.4 Business Strategies

 

TABLE 1 Market Snapshot: Global Cervical Cancer Diagnostic Tests Market

TABLE 2 Global Cervical Cancer Diagnostic Tests Market Revenue, by Type of Tests, 2012 - 2020 (USD Million)

TABLE 3 Global Cervical Cancer Diagnostic Tests Market Revenue, by Geography, 2012 – 2020 (USD Million)

 

FIG. 1 Global Cervical Cancer Diagnostic Tests Market Segmentation

FIG. 1 Global Cervical Cancer Diagnostic Tests Market, by Type of Tests, 2013 (USD Million)

FIG. 2 Comparative Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography, 2013 & 2020 (Value %)

FIG. 3 Cervical Cancer Diagnostic Tests Market, Drivers and Restraints

FIG. 4 Porter’s Five Forces Analysis: Cervical Cancer Diagnostic Tests Market

FIG. 5 Market Attractiveness Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography

FIG. 6 Heat Map Analysis of Key Market Players for the Cervical Cancer Diagnostic Tests Market

FIG. 7 Global Pap Smear Tests Market Revenue, 2012 – 2020 (USD Million)

FIG. 8 Global Colposcopy Market Revenue, 2012 – 2020 (USD Million)

FIG. 9 Global HPV Testing Market Revenue, 2012 – 2020 (USD Million)

FIG. 10 Global Endocervical Curettage (ECC) Market Revenue, 2012 – 2020 (USD Million)

FIG. 11 Global Other Cervical Cancer Diagnostic Tests Market Revenue, 2012 – 2020 (USD Million)

FIG. 12 North America Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

FIG. 13 Europe Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

FIG. 14 Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

FIG. 15 RoW Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

FIG. 16 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 17 Becton, Dickinson & Company: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 18 Hologic, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 19 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 20 Quest Diagnostics, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 21 QIAGEN N.V.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 22 Guided Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million)